PRTA Q3 2025 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+149.0% YoY

Gross Profit

-$27M-1098.3% margin

Operating Income

-$40M-1666.3% margin

Net Income

-$37M-1513.1% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

-45.4%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$41M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$353M

Total Liabilities

$58M

Stockholders' Equity

$295M

Cash & Equivalents

$331M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$970,000	+149.0%
Gross Profit	-$27M	$970,000	-2834.3%
Operating Income	-$40M	-$67M	+39.5%
Net Income	-$37M	-$59M	+38.1%

Revenue Segments

Collaboration

$2M100%